HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marlene Montesino Selected Research

Intravaginal Administration

11/2018Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
5/2016Serum steroid concentrations remain within normal postmenopausal values in women receiving daily 6.5mg intravaginal prasterone for 12 weeks.
3/2016Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
1/2016Evaluation of the acceptability of intravaginal prasterone ovule administration using an applicator.
11/2015Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marlene Montesino Research Topics

Disease

8Atrophy
11/2018 - 11/2015
6Dyspareunia
11/2018 - 11/2015
4Pain (Aches)
11/2018 - 11/2015

Drug/Important Bio-Agent (IBA)

8Dehydroepiandrosterone (DHEA)IBA
11/2018 - 11/2015
1Estradiol (Delestrogen)FDA LinkGeneric
11/2017
1Pharmaceutical PreparationsIBA
11/2017
1Conjugated (USP) Estrogens (Premarin)FDA Link
11/2017
1Suppositories (Vaginal Suppositories)IBA
01/2016
1SteroidsIBA
11/2015

Therapy/Procedure

5Intravaginal Administration
11/2018 - 11/2015